Catalyst Wire Dossier Catalyst Wire Dossier

Regranex

becaplermin
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Regranex, covering 2010-02-18 to 2016-07-19. Get the full timeline:

Most recent: Clinical Trial Update: The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])

See pricing